Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-078730·PFM Health Sciences, LP
Schedule 13G ownership disclosure
WEREWOLF THERAPEUTICS INC
Common stock, par value $0.0001 per share (the "Shares") · CUSIP: 95075A107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- PFM Health Sciences, LP
Shares: 401,110.00 · Class: 0.9%
- PFM Health Sciences GP, LLC
Shares: 401,110.00 · Class: 0.9%
- Partner Asset Management, LLC
Shares: 401,110.00 · Class: 0.9%
- Brian D. Grossman
Shares: 401,110.00 · Class: 0.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-078730
- Form type
- SCHEDULE 13G/A
- Filer
- PFM Health Sciences, LP
- CIK
- CIK 1442756
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership